MANNKIND CORP Adjustment of Warrants Granted for Services
MANNKIND CORP (MNKD) reported Adjustment of Warrants Granted for Services of -$2.71 million for the 256-month period ending 2012-06-30, per its 10-Q filed 2012-08-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:AdjustmentOfWarrantsGrantedForServices · last filed 2012-08-09
- MANNKIND CORP adjustment of warrants granted for services for the quarter ending 2012-06-30 was -$2.99M.
- MANNKIND CORP adjustment of warrants granted for services for the quarter ending 2012-03-31 was $284.00K.
| Period end | Adjustment of Warrants Granted for Services 3 month | Adjustment of Warrants Granted for Services 6 month | Adjustment of Warrants Granted for Services 253 month | Adjustment of Warrants Granted for Services 256 month |
|---|---|---|---|---|
| 2012-06-30 | -$2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$2.71M 10-Q · filed 2012-08-09 | -$2.71M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $284.00K 10-Q · filed 2012-05-10 | $284.00K 10-Q · filed 2012-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |